Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Total article views   HTML views PDF downloads Totals
11,572 Dovepress* 10,834+ 1,596 12,430
PubMed Central* 738 349 1,087
Totals 11,572 1,945 13,517
*Since 1 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
11 1 0 0 4 6

View citations on PubMed and Google Scholar